iPS Cells Reprogrammed From Primary Dendritic Cells Provide an Abundant Source of Immunostimulatory Dendritic Cells for Use in Immunotherapy
Stem Cells - United States
doi 10.1002/stem.3095
Full Text
Open PDFAbstract
Available in full text
Date
October 31, 2019
Authors
Publisher
Wiley